Developed a seven-gene prognosis model using univariate/multivariate Cox regression and LASSO methodology.
Patients in the low-risk group had significantly longer survival compared to the high-risk group (P < 0.0001).
The seven-gene model showed correlation with drug sensitivity and responses to immunotherapy.
High-risk patients exhibited increased Dysfunction Score and other immune-related scores compared to low-risk patients (P < 0.01 for Dysfunction Score).